Merit Medical Systems Future Growth
Future criteria checks 2/6
Merit Medical Systems is forecast to grow earnings and revenue by 15.8% and 5.1% per annum respectively. EPS is expected to grow by 15.4% per annum. Return on equity is forecast to be 8.7% in 3 years.
Key information
15.8%
Earnings growth rate
15.4%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 5.1% |
Future return on equity | 8.6% |
Analyst coverage | Good |
Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,470 | 159 | 153 | 222 | 7 |
12/31/2025 | 1,392 | 152 | 195 | 229 | 11 |
12/31/2024 | 1,320 | 129 | 134 | 175 | 11 |
12/31/2023 | 1,257 | 94 | 108 | 145 | N/A |
9/30/2023 | 1,226 | 100 | 68 | 111 | N/A |
6/30/2023 | 1,198 | 90 | 45 | 95 | N/A |
3/31/2023 | 1,173 | 85 | 65 | 117 | N/A |
12/31/2022 | 1,151 | 75 | 66 | 114 | N/A |
9/30/2022 | 1,136 | 62 | 89 | 132 | N/A |
6/30/2022 | 1,116 | 58 | 87 | 122 | N/A |
3/31/2022 | 1,101 | 48 | 90 | 124 | N/A |
12/31/2021 | 1,075 | 48 | 116 | 147 | N/A |
9/30/2021 | 1,054 | 43 | 105 | 138 | N/A |
6/30/2021 | 1,031 | 28 | 133 | 168 | N/A |
3/31/2021 | 969 | 4 | 131 | 172 | N/A |
12/31/2020 | 964 | -10 | 116 | 165 | N/A |
9/30/2020 | 964 | -29 | 96 | 155 | N/A |
6/30/2020 | 963 | -30 | 44 | 115 | N/A |
3/31/2020 | 1,000 | -4 | 16 | 93 | N/A |
12/31/2019 | 995 | 5 | -4 | 78 | N/A |
9/30/2019 | 970 | 19 | -3 | 75 | N/A |
6/30/2019 | 949 | 39 | 17 | 87 | N/A |
3/31/2019 | 918 | 43 | 24 | 92 | N/A |
12/31/2018 | 883 | 42 | 20 | 87 | N/A |
9/30/2018 | 840 | 40 | 23 | 82 | N/A |
6/30/2018 | 798 | 19 | 8 | 63 | N/A |
3/31/2018 | 760 | 18 | 8 | 55 | N/A |
12/31/2017 | 728 | 28 | 22 | 63 | N/A |
9/30/2017 | 695 | 28 | N/A | 61 | N/A |
6/30/2017 | 672 | 33 | N/A | 63 | N/A |
3/31/2017 | 637 | 31 | N/A | 57 | N/A |
12/31/2016 | 604 | 20 | N/A | 54 | N/A |
9/30/2016 | 580 | 19 | N/A | 49 | N/A |
6/30/2016 | 559 | 23 | N/A | 55 | N/A |
3/31/2016 | 546 | 23 | N/A | 62 | N/A |
12/31/2015 | 542 | 24 | N/A | 69 | N/A |
9/30/2015 | 537 | 26 | N/A | 79 | N/A |
6/30/2015 | 529 | 29 | N/A | 74 | N/A |
3/31/2015 | 520 | 25 | N/A | 65 | N/A |
12/31/2014 | 510 | 23 | N/A | 53 | N/A |
9/30/2014 | 497 | 21 | N/A | 49 | N/A |
6/30/2014 | 483 | 19 | N/A | 57 | N/A |
3/31/2014 | 464 | 19 | N/A | 56 | N/A |
12/31/2013 | 449 | 17 | N/A | 51 | N/A |
9/30/2013 | 431 | 11 | N/A | 48 | N/A |
6/30/2013 | 412 | 12 | N/A | 40 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MM3's forecast earnings growth (15.8% per year) is above the savings rate (0.6%).
Earnings vs Market: MM3's earnings (15.8% per year) are forecast to grow faster than the German market (15.1% per year).
High Growth Earnings: MM3's earnings are forecast to grow, but not significantly.
Revenue vs Market: MM3's revenue (5.1% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: MM3's revenue (5.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MM3's Return on Equity is forecast to be low in 3 years time (8.7%).